Clinical Trial Update: A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A first-in-human Phase 1 study of GSK3745417 in participants with advanced solid tumors has results posted; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• GSK3745417

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms | Phase 1 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-01-08